Burjeel completed the acquisition of an 80% stake in Advanced Care Oncology Center for $25m.

Burjeel, a super-specialty healthcare provider in the MENA region, completed the acquisition of an 80% stake in Advanced Care Oncology Center, a renowned provider for its specialized expertise in radiation therapy, nuclear medicine and chemotherapy services, for $25m. “Our vision is to establish a comprehensive and advanced oncology network in the GCC, addressing unmet needs in specialized cancer care. By building on ACOC’s legacy of excellence, we will bring accessible, high-quality radiation oncology services closer to patients, significantly enhancing cancer care outcomes across the region,” Mr. John Sunil, Burjeel CEO.